Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
about
Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designRole of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.Cardiac implantable electronic device lead-based masses and atrial fibrillation ablation: a case-based illustration of periprocedural anticoagulation management strategies.Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry.Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Filling defects of the left atrial appendage on multidetector computed tomography: their disappearance following catheter ablation of atrial fibrillation and the detection of LAA thrombi by MDCT.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
P2860
Q34691799-EC417325-358F-4BC4-B401-D933B10CD814Q37989837-BAB941B8-6A04-423F-985F-B743C9AC9013Q38100729-C8AC312C-4256-4D79-AA0F-BB28E32769CFQ38398014-D9AD4B66-E3BC-4AF9-9182-FBA936FE4CCFQ39981516-90840416-19B5-47E7-AD2E-606A6D45A32DQ40135161-B8D71EE1-3CA6-4721-900B-B6E4D706F3D8Q44007231-BC5F0C40-405C-4399-BF26-86848F131BC4Q44232261-BC76A9A1-53D9-4BDF-8519-F3BACC261587Q45059153-A6FBD796-73A6-4336-9A44-E77DB90637D4Q46658026-3BB0F756-0A3B-43DF-8E39-3B78E8BDB187Q52984558-68872060-4A35-40DE-8AFC-57583A4DC130Q55263071-733327AA-D8C5-4362-A172-82579A06338C
P2860
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@ast
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@en
type
label
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@ast
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@en
prefLabel
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@ast
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@en
P2093
P2860
P1433
P1476
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
@en
P2093
Matthew T Rondina
Sara R Vazquez
Stacy A Johnson
P2860
P304
P356
10.1016/J.THROMRES.2009.11.031
P577
2010-01-06T00:00:00Z